Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Hebart

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Journal of Clinical Microbiology|May 31, 2002
High variability between results of different in-house tests for cytomegalovirus (CMV) monitoring and a standardized quantitative plasma CMV PCR assayLutz Von Müller, Walter Hampl, Joachim Hinz, et al.
Journal of Clinical Microbiology|May 5, 2006
Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantationJuergen Loeffler, Michael Steffens, Eva-Maria Arlt, et al.
Blood|May 16, 2002
Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapyHermann Einsele, Eddy Roosnek, Nathalie Rufer, et al.
Experimental Hematology|October 11, 2003
A CTL epitope from human cytomegalovirus IE1 defined by combining prediction of HLA binding and proteasomal processing is the target of dominant immune responses in patients after allogeneic stem cell transplantationHolger Hebart, Georg Rauser, Stefan Stevanovic, et al.
Annals of Hematology|April 13, 2006
Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Olaf Penack, Thomas Beinert, Dieter Buchheidt, et al.
Oncology Research and Treatment|September 17, 2024
Guidelines of Onkopedia: What Is New? Locally Advanced Rectal CancerRalf-Dieter Hofheinz, Dirk Arnold, Markus Borner, et al.
British Journal of Haematology|December 16, 2016
Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemiaTadeusz Robak, Andrzej Hellmann, Janusz Kloczko, et al.
Annals of Hematology|October 15, 2008
Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Angelika Böhme, Markus Ruhnke, et al.
Journal of Cancer Research and Clinical Oncology|February 16, 2017
Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin careCarl Christoph Schimanski, Frank Staib, Thomas Göhler, et al.
Annals of Hematology|September 19, 2003
Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Hermann Einsele, Hartmut Bertz, Jörg Beyer, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Journal of Clinical Microbiology|May 31, 2002
High variability between results of different in-house tests for cytomegalovirus (CMV) monitoring and a standardized quantitative plasma CMV PCR assayLutz Von Müller, Walter Hampl, Joachim Hinz, et al.
Journal of Clinical Microbiology|May 5, 2006
Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantationJuergen Loeffler, Michael Steffens, Eva-Maria Arlt, et al.
Blood|May 16, 2002
Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapyHermann Einsele, Eddy Roosnek, Nathalie Rufer, et al.
Experimental Hematology|October 11, 2003
A CTL epitope from human cytomegalovirus IE1 defined by combining prediction of HLA binding and proteasomal processing is the target of dominant immune responses in patients after allogeneic stem cell transplantationHolger Hebart, Georg Rauser, Stefan Stevanovic, et al.
Annals of Hematology|April 13, 2006
Management of sepsis in neutropenia: guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Olaf Penack, Thomas Beinert, Dieter Buchheidt, et al.
Oncology Research and Treatment|September 17, 2024
Guidelines of Onkopedia: What Is New? Locally Advanced Rectal CancerRalf-Dieter Hofheinz, Dirk Arnold, Markus Borner, et al.
British Journal of Haematology|December 16, 2016
Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemiaTadeusz Robak, Andrzej Hellmann, Janusz Kloczko, et al.
Annals of Hematology|October 15, 2008
Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Angelika Böhme, Markus Ruhnke, et al.
Journal of Cancer Research and Clinical Oncology|February 16, 2017
Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin careCarl Christoph Schimanski, Frank Staib, Thomas Göhler, et al.
Annals of Hematology|September 19, 2003
Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Hermann Einsele, Hartmut Bertz, Jörg Beyer, et al.
Pageof 7